Mankind Pharma exits Broadway Hospitality in Rs 49 crore sale to AKRK Projects
Mankind Pharma has sold its entire stake in Broadway Hospitality Services to AKRK Projects LLP and its partners for Rs 49 crore, subject to closing adjustments. The transaction ends Broadway’s status as a wholly owned Mankind subsidiary.
What happened
Mankind Pharma completed the sale of its entire stake in Broadway Hospitality Services to AKRK Projects LLP and its partners for Rs 49 crore, subject to closing
Key facts
- 100% stake
- Rs 49 crore
- August 31, 2026
Why this matters
The sale removes a non-core wholly owned subsidiary from Mankind’s portfolio, illustrating the value of divesting adjacent businesses that lack strategic fit.
What to watch
- Transaction closing confirmation and final consideration after adjustments.
- Disclosure of gain or loss on sale, tax treatment, and impact on consolidated earnings.
- Management commentary on intended use of proceeds.
- Any subsequent sale, merger, or restructuring involving other non-pharma assets.
- Changes in Mankind's capex, acquisition pipeline, or shareholder-return policy following the divestment.
- Complete closing adjustments and formally deconsolidate Broadway Hospitality Services from financial reporting.
- Deploy sale proceeds into working capital, debt reduction, shareholder returns, or core pharma investments.
- Assess remaining non-core subsidiaries, investments, and real-estate-linked exposures for potential monetization.
- Communicate the strategic rationale and any expected accounting gain or loss in subsequent disclosures.